Literature DB >> 8920902

Activation and inhibition of reconstituted cardiac L-type calcium channels by palmitoyl-L-carnitine.

Q Y Liu1, R L Rosenberg.   

Abstract

We have studied the effect of a palmitoyl-L-carnitine (L-PC) on single cardiac L-type Ca channels incorporated from porcine ventricular sarcolemma into planar lipid bilayers where we could control the concentration, intracellular and/or extracellular location, and duration of L-PC treatment. We found that 1.0 microM L-PC in either the intracellular or extracellular chamber caused an approximately 8 fold increase in channel open probability when measured within the first minute after L-PC addition. Higher concentrations of L-PC did not increase open probability to the same extent as 1.0 microM. In addition, we found that L-PC had biphasic effects on the open probability of L-type Ca channels, causing an increase in activity immediately after the addition of L-PC, but leading to a decrease in open probability after a few minutes. Higher concentrations of L-PC (10 microM) also caused a decrease in single-channel conductance from 26 to 21 pS (measured in 100 mM external Ba2+). The effects of L-PC were similar on both sides of the channels, suggesting that alterations in the physical properties of the membrane surrounding the channels may be responsible for the effects of L-PC. These changes in Ca channel activity may participate in the generation of abnormal electrical activity and arrhythmogenesis during ischemia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8920902     DOI: 10.1006/bbrc.1996.1649

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

Review 1.  Regulation of ion channels in myocardial cells and protection of ischemic myocardium.

Authors:  N Sperelakis; M Sunagawa; H Yokoshiki; T Seki; M Nakamura
Journal:  Heart Fail Rev       Date:  2000-06       Impact factor: 4.214

2.  Effects of arrhythmogenic lipid metabolites on the L-type calcium current of diabetic vs. non-diabetic rat hearts.

Authors:  M T Ziolo; K L Sondgeroth; C H Harshbarger; J M Smith; G M Wahler
Journal:  Mol Cell Biochem       Date:  2001-04       Impact factor: 3.396

Review 3.  Lipid metabolites and their differential pro-arrhythmic profiles: of importance in the development of a new anti-arrhythmic pharmacology.

Authors:  Yangzhen Shao; Bjorn Redfors; David Benoist; Sigfus Gizurarson; Elmir Omerovic
Journal:  Mol Cell Biochem       Date:  2014-04-27       Impact factor: 3.396

4.  Palmitate increases L-type Ca2+ currents and the size of the readily releasable granule pool in mouse pancreatic beta-cells.

Authors:  Charlotta S Olofsson; Albert Salehi; Cecilia Holm; Patrik Rorsman
Journal:  J Physiol       Date:  2004-04-16       Impact factor: 5.182

Review 5.  Acylcarnitines--old actors auditioning for new roles in metabolic physiology.

Authors:  Colin S McCoin; Trina A Knotts; Sean H Adams
Journal:  Nat Rev Endocrinol       Date:  2015-08-25       Impact factor: 43.330

6.  Long-chain acylcarnitines regulate the hERG channel.

Authors:  Fabio Ferro; Aude Ouillé; Truong-An Tran; Pierre Fontanaud; Patrick Bois; Dominique Babuty; François Labarthe; Jean-Yves Le Guennec
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

7.  Downregulation of carnitine acyl-carnitine translocase by miRNAs 132 and 212 amplifies glucose-stimulated insulin secretion.

Authors:  Mufaddal S Soni; Mary E Rabaglia; Sushant Bhatnagar; Jin Shang; Olga Ilkayeva; Randall Mynatt; Yun-Ping Zhou; Eric E Schadt; Nancy A Thornberry; Deborah M Muoio; Mark P Keller; Alan D Attie
Journal:  Diabetes       Date:  2014-06-26       Impact factor: 9.461

8.  Dissecting Cellular Mechanisms of Long-Chain Acylcarnitines-Driven Cardiotoxicity: Disturbance of Calcium Homeostasis, Activation of Ca2+-Dependent Phospholipases, and Mitochondrial Energetics Collapse.

Authors:  Alexey V Berezhnov; Evgeniya I Fedotova; Miroslav N Nenov; Vitaly A Kasymov; Oleg Yu Pimenov; Vladimir V Dynnik
Journal:  Int J Mol Sci       Date:  2020-10-10       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.